The Food and Drug Administration’s top staff regulators were against shielding drug makers from lawsuits, the Los Angeles Times reports. Internal documents released by Rep. Henry A. Waxman (D-Beverly Hills)…
Read More
A woman who claimed diet drugs caused her lung-destroying disease has been awarded $3 million by a New Jersey jury, Bloomberg News reports. The verdict against Wyeth, the maker of…
Read More
The results of the long-awaited Canadian study on the anti-bleeding drug Trasylol were announced today in the New England Journal of Medicine. Researchers found that patients who were given Trasylol,…
Read More
A study released on Dec. 2 confirms what many previous studies have already found: Patients given the anti-bleeding drug Trasylol have a higher risk of dying than those who receive…
Read More
A federal advisory panel concluded that two drugs, Serevent and Foradil, should be banned for use in the treatment of asthma, according to Reuters. Studies have shown that when Serevent…
Read More
Bayer is finally removing the remaining supplies of Trasylol from the U.S. market after a long-awaited Canadian study confirmed yet again that the anti-bleeding drug is dangerous. On May 14,…
Read More
February 6, 2012 St. Louis – St. Louis–based law firm Carey, Danis & Lowe announces the filing of a lawsuit on behalf of 18 plaintiffs against Pfizer (NYSE: PFE), maker…
Read More
Avastin one of the new generation of gentler cancer drugs according to a report published in the Journal of the American Medical Association called for a “black box” warning --…
Read More
According to an announcement made by the U.S. Food and Drug Administration, Bayer’s clotting drug Trasylol will now only be available for investigational use. To use Trasylol, a doctor must…
Read More
On Nov. 3, the U.S. Supreme Court will hear oral arguments in an important case which could threaten the rights of consumers to sue drug makers over dangerous prescription medicines.…
Read More